Verve Therapeutics (VERV) Presents At 40th Annual J.P. Morgan Virtual Healthcare Conference

1 Verve Therapeutics Disrupting the Care of Cardiovascular Disease through Single-course Gene Editing Medicines January 2022 Forward looking statements This presentation contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 that involve substantial risks and uncertainties, including statements regarding the initiation, and timing, of the Company's planned regulatory submissions, future clinical trials, its research and development plans and the pote ...